L. Reyes

Therapeutic vaccination with MVA E2 can eliminate precancerous lesions (CIN 1, CIN 2, and CIN 3) associated with infection by oncogenic human papillomavirus.

R. Rosales, Tania Navarro, Carlos Manuel Corona Gutierrez, 2004, Human gene therapy.

Clinical Protocol A Phase II Study: Efficacy of the Gene Therapy of the MVA E2 Recombinant Virus in the Treatment of Precancerous Lesions (NIC I and NIC II) Associated with Infection of Oncogenic Human Papillomavirus

R. Rosales, Tania Navarro, Alberto Tinoco, 2002 .

Regression of papilloma high-grade lesions (CIN 2 and CIN 3) is stimulated by therapeutic vaccination with MVA E2 recombinant vaccine

R. Rosales, E. Garc, J. Gónzalez-Sánchez, 2006, Cancer Gene Therapy.